ORMP - Oramed Pharmaceuticals Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ORMP (1176309)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
7 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1+2+21+0+0
S1+2+21+0+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-08-09
ORMPFriedman AviadDirP - Purchase$4.95+2,50022,191+13%+$12,370
2018-07-10
ORMPKidron NadavPres, CEO, 10%S - Sale$5.98-61958,2090%-$365
2018-07-11
ORMPKidron NadavPres, CEO, 10%P - Purchase$5.92+122958,2090%+$722
2017-08-02
ORMPLi XiaopengDirP - Purchase$8.50+89,636206,350+77%+$761,906
2017-08-02
ORMPKidron MiriamChief Scientific OfficerS - Sale$8.50-89,63675,000-54%-$761,906
2017-04-19
ORMPLi XiaopengDirP - Purchase$6.33+52,814116,714+83%+$334,313+2+21
2017-04-19
ORMPKidron MiriamChief Scientific OfficerS - Sale$6.33-52,81489,636-37%-$334,313+2+21
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top